Cargando…
The Tuberculosis Vaccine Candidate Bacillus Calmette-Guérin ΔureC::hly Coexpressing Human Interleukin-7 or -18 Enhances Antigen-Specific T Cell Responses in Mice
Bacillus Calmette–Guérin (BCG), the only approved tuberculosis vaccine, provides only limited protection. Previously, we generated a recombinant derivative (BCG ΔureC::hly), which secretes the pore-forming toxin listeriolysin O (LLO) of Listeria monocytogenes. This vaccine shows superior protection...
Autores principales: | Rao, Martin, Vogelzang, Alexis, Kaiser, Peggy, Schuerer, Stefanie, Kaufmann, Stefan H. E., Gengenbacher, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827306/ https://www.ncbi.nlm.nih.gov/pubmed/24236077 http://dx.doi.org/10.1371/journal.pone.0078966 |
Ejemplares similares
-
Dietary Pyridoxine Controls Efficacy of Vitamin B(6)-Auxotrophic Tuberculosis Vaccine Bacillus Calmette-Guérin ΔureC::hly Δpdx1 in Mice
por: Gengenbacher, Martin, et al.
Publicado: (2014) -
Central Memory CD4(+) T Cells Are Responsible for the Recombinant Bacillus Calmette-Guérin ΔureC::hly Vaccine's Superior Protection Against Tuberculosis
por: Vogelzang, Alexis, et al.
Publicado: (2014) -
Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis
por: Gengenbacher, Martin, et al.
Publicado: (2016) -
Recombinant BCG ΔureC hly+ Induces Superior Protection Over Parental BCG by Stimulating a Balanced Combination of Type 1 and Type 17 Cytokine Responses
por: Desel, Christiane, et al.
Publicado: (2011) -
Archaeal amoA and ureC genes and their transcriptional activity in the Arctic Ocean
por: Pedneault, Estelle, et al.
Publicado: (2014)